Fresenius SE & Co. KGaA

Earnings Release • Jul 27, 2010

News Details

Ad-hoc | 27 July 2010 19:09

Fresenius SE: First half of 2010: Preliminary Group net income substantially better than expected − Earnings outlook raised

Fresenius SE / Half Year Results/Preliminary Results

27.07.2010 19:09

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

First half of 2010: Preliminary Group net income substantially better than
expected − Earnings outlook raised

Based on preliminary results, Fresenius Group earnings for the first half
of 2010 were substantially ahead of expectations. Group net income*
increased by 23% in constant currency to EUR302 million (H1 2009: EUR240
million).

The earnings development was mainly driven by Fresenius Kabi, especially in
North America, where new product launches and strong demand due to drug
shortages contributed to growth.

Fresenius Kabi also expects to achieve attractive growth in the second half
of 2010, albeit more in line with the initial 2010 guidance. In addition,
Fresenius Kabi plans to invest in further efficiency improvements in
Europe, resulting in expected one-time expenses of approximately EUR10
million to EUR20 million pre-tax in the second half of 2010.

Based on the Group's financial results in the first half and including the
planned one-time expenses, Fresenius now expects net income* to increase by
10% to 15% in constant currency in 2010. Previously, the Company expected
net income to increase by 8% to 10% in constant currency.

The detailed financial results for the first half of 2010 will be announced
on August 3, 2010, as originally scheduled.

*Net income attributable to Fresenius SE; adjusted for the effects of
mark-to-market accounting of the Mandatory Exchangeable Bonds (MEB) and the
Contingent Value Rights (CVR) related to the acquisition of APP
Pharmaceuticals. Both are non-cash items.

The Management Board

Bad Homburg v.d.H., July 27, 2010

End of note

27.07.2010 Ad hoc announcement, Financial News and Press Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Fresenius SE
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Deutschland
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: ir-fre@fresenius.com
Internet: www.fresenius.com
ISIN: DE0005785638, DE0005785604
WKN: 578563, 578560
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard), Düsseldorf,
München; Freiverkehr in Berlin, Hannover, Stuttgart, Hamburg;
Terminbörse EUREX

End of News DGAP News-Service

---